The utility of phospholipase A2 receptor autoantibody in membranous nephropathy after kidney transplantation

Membranous nephropathy (MN) is estimated to cause end-stage renal disease in ∼ 5% of patients, in whom renal transplantation is the therapy of choice. Among patients receiving a transplant for MN, the disease will recur in the graft in 30–50%; among these, graft loss will occur in 50% within 10 year...

Descripción completa

Detalles Bibliográficos
Autores principales: Xipell, Marc, Rodas, Lida M, Villarreal, Jesús, Molina, Alicia, Reinoso-Moreno, Johanna, Blasco, Miquel, Poch, Esteban, Diekmann, Fritz, Campistol, Jose M, Quintana, Luis F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007417/
https://www.ncbi.nlm.nih.gov/pubmed/29988247
http://dx.doi.org/10.1093/ckj/sfx128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007417/
https://www.ncbi.nlm.nih.gov/pubmed/29988247
http://dx.doi.org/10.1093/ckj/sfx128

Ejemplares similares